BLISTEX RELIEF CREAM

Indications

• Rectal and anal disorders
• Haemorrhoids
• Pruritus ani

Dosage

Children: Refer to the BNF for Children for appropriate dosing information.

Adults: For rectal use using aerosol spray: 1 spray up to 3 times a day for no longer than 7 days without medical advice. For ointment: apply several times daily, for short-term use only.

Mechanism of action

Phenol exerts its effects by acting as a potent proteolytic agent. At concentrations of 5% to 7%, it can dissolve tissue through proteolysis. When injected near a nerve, it produces chemical neurolysis, affecting nerve fibers nonselectively. Local anesthetic effects are typically observed within 5 to 10 minutes of application.

Pharmacodynamics

Phenol's pharmacodynamic properties include its ability to cause tissue dissolution and local anesthesia. The local anesthetic effects result from its action on the nerve fibers, leading to a temporary loss of sensation in the affected area. The proteolytic action can assist in the treatment of various skin and mucosal conditions by facilitating tissue breakdown.

Pharmacokinetics

Phenol is absorbed through mucosal surfaces when applied locally. Its metabolism involves biological oxidation and phase I functionalization, primarily through cytochrome P450 enzymes. The elimination of phenol occurs through metabolic pathways, and it can be detected in urine as a result of its metabolism.

Contra-indications

• Infection
• Known hypersensitivity to phenol or its components

Adverse effects

• Local irritation
• Burning sensation
• Paraesthesia
• Vision disorders
• Skin reactions
• Adrenal suppression

Interactions

• Caution with other local anesthetics due to potential additive effects

Precautions

• Use for short periods only-no longer than a few days
• Avoid excessive application, especially on sensitive areas
• Consult product literature for specific guidelines

Pregnancy

Data on the use of phenol during pregnancy is limited; caution is advised.

Breast-feeding

Limited information available; caution is recommended when used in breastfeeding mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Ointment
• Suppository
• Aerosol spray

Indications

• Hepatic encephalopathy
• Urea cycle disorders
• Acid-base disturbances

Dosage

Children: Refer to the BNF for Children for specific pediatric dosing information.

Adults: Refer to the BNF for specific dosing information based on condition and clinical guidelines.

Mechanism of action

Ammonia is crucial for renal excretion and metabolism, which aids in the regulation of acid-base balance by generating bicarbonate ions and promoting renal net acid excretion. Acute exposure to ammonia can activate NMDA receptor signaling pathways, while high concentrations resulting from urea cycle enzyme deficiencies can cause alterations in astrocyte morphology and increased neuroactive metabolites. This includes oxidative/nitrosative stress that impacts neuronal and astrocytic function, contributing to cerebral ammonia toxicity and related neuropsychiatric effects.

Pharmacodynamics

As a gas, ammonia acts as a natural respiratory stimulant. Its renal metabolism contributes to whole body acid-base balance, while its toxic effects at elevated levels can lead to significant neurophysiological changes, particularly in the context of liver dysfunction. Ammonia's role in stimulating oxidative stress responses in brain cells can lead to cellular damage and altered signaling pathways.

Pharmacokinetics

Ammonia is primarily metabolized in the liver, where it is converted to urea through the urea cycle, facilitating its excretion. The balance of ammonia production and clearance is critical for maintaining normal physiological functions. Following inhalation, ammonia is rapidly absorbed and can cause irritation in the respiratory tract. Renal function significantly influences ammonia levels in the body, with changes in kidney function affecting its excretion and thus systemic concentrations.

Pregnancy

Ammonia is generally considered unsafe during pregnancy due to potential risks to fetal development.

Breast-feeding

Ammonia may be present in breast milk; caution is advised.

Storage

Store in a cool, dry place, away from direct sunlight and incompatible substances.

Indications

• Analgesic
• Anti-inflammatory
• Antimicrobial
• Antidepressant
• Anticancer
• Sedative
• Anxiolytic

Dosage

Children: Refer to the BNF for Children for appropriate dosing information, as specific doses will depend on the individual aromatic compound and its clinical application.

Adults: Refer to specific drug formulations for dosing information, as aromatic compounds encompass a wide range of substances with varying indications and dosing regimens.

Mechanism of action

The mechanism of action of aromatic compounds varies widely depending on the specific compound and its application. Generally, these compounds can interact with biological receptors, enzymes, or other molecular targets, leading to changes in cellular signaling pathways. For example, some aromatic compounds may act as agonists or antagonists of neurotransmitter receptors, influencing physiological responses.

Pharmacodynamics

Pharmacodynamics of aromatic compounds is influenced by their structural characteristics, which allow them to interact with various biological targets. These interactions can lead to diverse effects, including modulation of enzyme activity, alteration of ion channel functions, and interaction with nuclear receptors. The pharmacodynamic profile is crucial in determining the therapeutic efficacy and safety of drugs containing aromatic moieties.

Pharmacokinetics

The pharmacokinetics of aromatic compounds depend on factors such as lipophilicity, molecular weight, and functional groups present. Generally, these compounds can be absorbed through oral, dermal, or inhalational routes. After absorption, they are distributed throughout the body, often binding to plasma proteins. Metabolism typically occurs in the liver through phase I and phase II reactions, leading to the formation of various metabolites. Excretion mainly occurs via urine or feces, and half-lives can vary significantly among different compounds.

Pregnancy

The safety of aromatic compounds during pregnancy varies depending on the specific compound. Some aromatics may be considered safe, while others can pose risks to fetal development. Consultation with a healthcare provider is essential.

Breast-feeding

Many aromatic compounds may pass into breast milk. The safety of specific aromatics during breastfeeding should be assessed individually, and healthcare providers should be consulted.

Storage

Aromatic compounds should be stored in well-sealed containers, away from light and moisture, and at room temperature unless otherwise specified.

Indications

• Asthma
• Chronic obstructive pulmonary disease (COPD)
• Allergic rhinitis
• Local or systemic anesthesia
• Mucolytic therapy in respiratory conditions

Dosage

Children: Refer to specific drug guidelines for paediatric dosing, which will depend on the active ingredient and the child's age, weight, and clinical condition.

Adults: Refer to specific drug guidelines for dosing information, as the dosage will vary depending on the active ingredient in the liquefied formulation and the condition being treated.

Mechanism of action

Liquefaction itself does not have a specific mechanism of action as it is a physical process rather than a pharmacological one. However, for liquefied medications, the mechanism of action would depend on the active pharmaceutical ingredient (API) included in the formulation. For example, liquefied corticosteroids used in inhalers work by reducing inflammation in the airways, while liquefied anesthetics may block nerve conduction when administered.

Pharmacodynamics

The pharmacodynamics of liquefied medications will vary based on the specific drug being delivered in a liquefied form. Generally, the efficacy and safety of liquefied medications are influenced by factors such as the concentration of the drug, the delivery method, and the patient's physiological conditions. For instance, liquefied bronchodilators act by relaxing bronchial smooth muscle, leading to bronchodilation and improved airflow.

Pharmacokinetics

The pharmacokinetics of liquefied medications depend on the formulation and the route of administration. Liquefied drugs administered via inhalation typically have rapid onset due to direct delivery to the lungs, leading to quick absorption into the systemic circulation. Factors such as particle size, viscosity, and solubility can affect the rate and extent of absorption. The distribution, metabolism, and excretion of the active ingredient will follow standard pharmacokinetic principles relevant to that specific drug.

Pregnancy

Consult a healthcare professional before use. Safety during pregnancy has not been established.

Breast-feeding

Consult a healthcare professional before use. Safety during breastfeeding has not been established.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Severe pain management
• Acute inflammatory conditions
• Chronic pain syndromes
• Postoperative pain relief
• Cancer-related pain
• Severe anxiety or depression (specific agents)

Dosage

Children: Refer to BNF for Children for specific paediatric dosing recommendations based on age, weight

Adults: Refer to specific guidelines or BNF for exact dosing information based on the drug type and condition being treated.

Mechanism of action

The mechanism of action for strong medications can vary significantly. For example, opioids work by binding to specific receptors in the central nervous system (CNS), primarily mu-opioid receptors, which leads to inhibition of pain signaling and modulation of emotional responses to pain. NSAIDs typically exert their effects by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), leading to decreased production of prostaglandins, which are mediators of inflammation and pain. Other strong medications may act through different pathways, such as altering neurotransmitter levels or modulating immune responses.

Pharmacodynamics

Pharmacodynamics of strong medications includes their effects on the body, particularly in terms of analgesia, anti-inflammatory effects, or modulation of various physiological systems. The efficacy of these medications is often assessed through their impact on pain relief, reduction of inflammation, or improvement in mood or anxiety levels. Tolerance and dependence may develop with long-term use of certain strong medications, particularly opioids, necessitating careful management.

Pharmacokinetics

Pharmacokinetics of strong medications encompasses absorption, distribution, metabolism, and excretion (ADME). For example, opioids are typically well-absorbed orally and undergo significant first-pass metabolism in the liver, which can affect bioavailability. The volume of distribution varies, influencing how the drug is distributed throughout the body, while the elimination half-life can differ widely among strong medications, impacting dosing frequency and duration of action.

Pregnancy

Consult a healthcare provider for risk assessment, as safety data may be limited.

Breast-feeding

Consult a healthcare provider, as the effects on nursing infants are not well studied.

Storage

Store in a cool, dry place away from direct sunlight, and keep out of reach of children.

Mechanism of action

Renal excretion and metabolism of ammonia is critical in regulation of acid-base balance by generating bicarbonate ions and promoting renal net acid excretion, both under basal conditions and in response to acid-base disturbances. There is evidence that acute ammonia exposure activates NMDA receptor signalling pathways, and high concentrations of ammonia resulting from urea cycle enzyme deficiencies are associated with changes in astrocyte morphology due to glutamine accumulation, changes in the expression of key astrocyte proteins, and increased concentrations of neuroactive L-tryptophan metabolites. ... Ammonia plays a key role in the pathogenesis of hepatic encephalopathy, which manifests as a neuropsychiatric syndrome accompanying acute and chronic liver failure. One consequence of ammonia action on the brain is astrocyte swelling, which triggers the generation of oxidative/nitrosative stress at the level of NADPH oxidase, nitric oxide synthases and the mitochondria. A self-amplifying signaling loop between oxidative stress and astrocyte swelling has been proposed. Consequences of the ammonia-induced oxidative/nitrosative stress response are protein modifications through nitration of tyrosine residues and oxidation of astrocytic and neuronal RNA. Nitrosative stress also mobilizes zinc from intracellular stores with impact on gene expression. These alterations may at least in part mediate cerebral ammonia toxicity through disturbances of intracellular and intercellular signaling and of synaptic plasticity. Oxidative/nitrosative stress and a low-grade cerebral edema as key events in the pathogenesis of ammonia toxicity and hepatic encephalopathy may offer potential new strategies for treatment. Ammonia-induced oxidation of RNA and proteins may impair postsynaptic protein synthesis, which is critically involved in learning and memory consolidation. RNA oxidation offers a novel explanation for multiple disturbances of neurotransmitter systems and gene expression and the cognitive deficits observed in hepatic encephalopathy. SRP: Ammonia in an aqueous environment exists in equilibrium between ionized ammonium cation and the non-ionized ammonia. This equilibrium can be affected by buffers, pH, temperature, and salinity. Thus in many cases it is not possible to assign the associated toxicity to the ionized or non-ionized form of the ammonia-nitrogen. /Aqueous ammonia/ Mechanisms involved in hepatic encephalopathy (HE) still remain poorly understood. It is generally accepted that ammonia plays a major role in this disorder, and that astrocytes represent the principal target of ammonia neurotoxicity. In recent years, studies from several laboratories have uncovered a number of factors and pathways that appear to be critically involved in the pathogenesis of this disorder. Foremost is oxidative and nitrosative stress (ONS), which is largely initiated by an ammonia-induced increase in intracellular Ca(2+). Such increase in Ca(2+) activates a number of enzymes that promote the synthesis of reactive oxygen-nitrogen species, including constitutive nitric oxide synthase, NADPH oxidase and phospholipase A2. ONS subsequently induces the mitochondrial permeability transition, and activates mitogen-activated protein kinases and the transcription factor, nuclear factor-kappaB (NF-kappaB). These factors act to generate additional reactive oxygen-nitrogen species, to phosphorylate various proteins and transcription factors, and to cause mitochondrial dysfunction. This article reviews the role of these factors in the mechanism of HE and ammonia toxicity with a focus on astrocyte swelling and glutamate uptake, which are important consequences of ammonia neurotoxicity.... A new model for ammonia excretion in freshwater fish and its variable linkage to Na(+) uptake and acid excretion /is proposed/. In this model, /the Rhesus protein/ Rhag facilitates NH(3) flux out of the erythrocyte, Rhbg moves it across the basolateral membrane of the branchial i

Pharmacodynamics

As a gas, ammonia is a natural byproduct and respiratory stimulant. Its renal metabolism plays a role in whole body acid-base balance.

Mechanism of action

Phenol is a potent proteolytic agent. Concentrations in the 5% to 7% range dissolve tissue on contact via proteolysis. In high concentrations when injected next to a nerve, phenol produces a chemical neurolysis which is nonselective across nerve fiber size and most prominent on its outer aspect. Local anesthetic effects occur within 5-10 minutes. The effects of monoamine depletors and monoamine denervators on phenol induced tremor were studied in mice. The tremor induced by phenol was enhanced by pretreatment with reserpine or tetrabenazine, but not with syrosingopine. However, alpha-methyl-p-tyrosine, p-chlorophenylalanine or 6-hydroxydopamine did not affect the tremor. These results suggest that the depletion of central monoamines as a whole contribute to the enhancement of the tremor induced by phenol.